Your patients live between your appointments. Measurement should too.
Entrelacs is building the person-specific measurement instrument for mental health care — conversational, clinically grounded, and engineered toward regulatory clearance. We're opening a limited clinical partner program for the clinics, health systems and research groups that will shape that path with us.
Care is continuous. Measurement is episodic.
Clinical assessment today happens at the moments care can see: intake, sessions, crisis. Between those moments, where deterioration takes shape, standard instruments are silent. And the instruments themselves were normed on populations, not persons: two patients with identical scores can be struggling for entirely different reasons, and a score benchmarked against the average patient can point a clinician toward the wrong pathway for the real one.
The measurement science to do better now exists. Person-specific network modeling — the approach at Entrelacs' core — reads each individual against their own subgroup baseline rather than a population norm, and reports not just severity but which domain matters most for that person.
Measurement built for individuals — designed for clinical standards from day one.
Person-specific measurement, validated step by step
Lacis builds a person-specific model of social connection and its impact on well-being. Patients engage with the conversational interface, while the deterministic psychometrics run reliably underneath. The AI handles the conversation; it doesn't score, assess, or diagnose.
Clinical governance, not just claims
Our Chief Clinical Officer is a practicing clinical psychologist with fifteen years in care. We are forming a six-member cross-market Clinical Advisory Board, anchored in the US and France, with at least half its seats held by clinicians currently seeing patients, to govern the platform's clinical boundaries.
A regulatory trajectory, stated precisely
Entrelacs today is a measurement and development instrument — not a diagnostic, not a treatment — deployed within clinical boundaries governed by our CCO and advisory board. We have filed an FDA Pre-Submission and are pursuing De Novo classification in the US, alongside CE Mark Class IIa in the EU targeted for 2027, supported by ongoing validation studies and a French clinical track.
Where this goes next — with partners, not just customers.
The same instrument that makes workforce capacity measurable is being built toward population-scale mental health measurement: the early-detection foundation that cardiology and oncology have relied on for decades. Getting there takes longitudinal evidence generated in real care settings.
Who we're building this with
Clinics and health systems deploying the instrument commercially on per-patient platform fees, generating real-world evidence with us
Research groups in our multi-country validation network, building the longitudinal cohorts behind the next generation of the engine
Payers and public health bodies exploring what person-specific connection measurement means for population risk — a conversation that becomes commercial after clearance, and starts now.
If you need help now
Entrelacs is a measurement instrument, not a crisis service. If you need help now, it can only point you toward it.
If you're struggling, or worried about someone else, talk to a person — your doctor, a crisis line, or someone you trust. Your employer is not involved and cannot see that you looked.
- US — 988 Suicide & Crisis Lifeline, call or text 988
- France — 3114, national suicide prevention line
- UK — Samaritans, 116 123
- Elsewhere — findahelpline.com lists services by country
- Immediate danger — emergency services
If something in your report worried you, take it to a professional rather than sitting with it.
Start measuring the asset
everything else depends on.
Entrelacs is onboarding a limited design-partner cohort: organizations ready to deploy org-wide, on founding-partner terms.